New COVID-19 Variant NB.181 Detected in US: Concerns Rise Amidst Vaccine Controversy

A new COVID-19 variant, NB.181, has been detected in the United States, raising concerns among health officials. Initially identified in China, the variant has spread to other Asian countries, causing a surge in cases. The Centers for Disease Control and Prevention (CDC) detected the first US cases between March and April through a screening program at airports. "The first cases in the United States were registered between March and April through a program applied in airports to international travelers," reports Latinus. The video shows footage of airport screenings and COVID testing sites across the country. Symptoms include sore throat, fever, and fatigue, but it is not considered more severe than previous variants. However, health officials are concerned about its higher transmissibility. Adding to the complexity, the Trump administration's decision to cancel COVID-19 vaccines for healthy children and pregnant women has sparked further debate. The situation underscores the ongoing challenges in managing the pandemic and the importance of continued vigilance.